Autism spectrum disorders: emerging pharmacotherapy

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.3, 2005-08, pp. : 521-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The status of pharmacotherapy for autism spectrum disorders

By Myers Scott M

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1579-1603

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy of Anxiety and Repetitive Behaviors in Autism Spectrum Disorders

Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 1, 2014-02 ,pp. : 5-9

Guilford Publications Inc

Access to resources Recommend Favorite

Emerging drugs for the treatment of symptoms associated with autism spectrum disorders

By Wink Logan K Plawecki Martin H Erickson Craig A Stigler Kimberly A McDougle Christopher J

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 3, 2010-09 ,pp. : 481-494

Informa Healthcare

Access to resources Recommend Favorite

Glutamate-Mediated Signaling and Autism Spectrum Disorders: Emerging Treatment Targets

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5186-5193

Bentham Science Publishers

Access to resources Recommend Favorite

Melatonin in Autism Spectrum Disorders

Current Clinical Pharmacology, Vol. 9, Iss. 4, 2014-11 ,pp. : 326-334

Bentham Science Publishers

Access to resources Recommend Favorite